The Effect of Ear Plug and Eye Mask on Sleeping Quality in Critically Ill Patients (sayed)

June 6, 2017 updated by: Sayed Kaoud Abd-Elshafy, Assiut University
Sleep is a complex physiologic and behavioral process essential for rest, repair, well-being, and survival. Sleep is defined as a periodic, reversible state of cognitive and sensory disengagement from the external environment. Critically ill patients experience poor sleep quality. Surveys of ICU survivors have shown that sleep disruption, pain and intubation for mechanical ventilation are the major sources of anxiety and stress during the ICU stay. Many physiological, psychological and environmental factors contribute to the incidence of sleep disruption for the ICU patients. The primary physiologic factors documented in the literature are pain, medications and illness.The primary psychological factors documented in the literature are stress and worry. Environmental factors include noise, patient care activities and therapeutic modalities as mechanical ventilation. Our research aim will be the impact of effective interventions like use of ear plugs and eye mask on decreasing light exposure and promoting sleep in ICU patients.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

50 patients in the age range 18- 60 years admitted to ICU of Assiut university hospitals will be randomly allocated into into two groups (control group and intervention group).

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Assiut, Egypt, 74111
        • Faculty of medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age >18 years old.
  • Mechanically ventilated patient.
  • Conscious patient.
  • No hearing problems.
  • No eye disease.
  • Not receiving narcotic drugs five to six hours before sleep time at night.
  • No underlying disease that is affecting sleep such as rheumatoid arthritis and migraine.

Exclusion Criteria

  • Head injury.
  • Psychiatric disease.
  • Shocked patients

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: ear plug and eye mask
  • The patients will not receive the intervention in the first night (N1) from 9 pm to 6 am
  • The patients will receive the intervention (eye mask) in the second night (N2) from 9 pm to 6 am.
  • The patients will receive the intervention (ear plug) in the third night (N3) from 9 pm to 6 am.
  • The patients will receive the intervention (eye mask and ear plug) in the fourth night (N4) from 9 pm to 6 am.
The patients will receive the intervention (ear plug) in the third night (N3) from 9 pm to 6 am.
Other Names:
  • eastnova ear plug
The patients will receive the intervention (eye mask) in the second night (N2) from 9 pm to 6 am.
Other Names:
  • Sleeping mask
No Intervention: control
The researcher will assess and observe the patients who are receiving the routine hospital nursing care during the four nights.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sleep quality .
Time Frame: four days
to assess sleep quality by using quality of sleep questionnaire or the Richards-Campbell Sleep Questionnaire (RCSQ) (measured by Units on a Scale)
four days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Urine Melatonin
Time Frame: four days
as urine Melatonin ( pg/mL)
four days
Cortisol level
Time Frame: four days
stress hormone as cortisol level (nmol/L)
four days
Delirium assessment
Time Frame: four days
Assessment of delirium by using NEECHAM confusion scale or Nursing delirium screening scale (measured by Units on a Scale)
four days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: sayed abd elshafy, Associate professor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2015

Primary Completion (Actual)

May 1, 2017

Study Completion (Actual)

May 1, 2017

Study Registration Dates

First Submitted

November 16, 2015

First Submitted That Met QC Criteria

November 23, 2015

First Posted (Estimate)

November 24, 2015

Study Record Updates

Last Update Posted (Actual)

June 7, 2017

Last Update Submitted That Met QC Criteria

June 6, 2017

Last Verified

June 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • IRB0000871100

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sleep

Clinical Trials on ear plug

Subscribe